Category:Disease

A

• [×] Aging-associated diseases (0)
• [+] Ailments of unknown etiology (1)
• [+] Animal diseases (8)

B

• [×] Blood disorders (0)

C

• [+] Types of cancer (3)
• [+] Cardiovascular diseases (2)
• [+] Disease related charities (8)
• [+] Congenital disorders (1)
• [×] Culture-specific syndromes (0)

D

• [+] Digestive diseases (1)
• [×] Diseases involving the fasciae (0)

E

• [×] Electrolyte disturbance (0)
• [+] Endocrinology (11)

F

• [+] Fictional diseases (1)
• [×] Foot diseases (0)

G

• [+] Gastroenterology (7)
• [×] Genetic Disease (0)
• [+] Genetic disorders (10)
• [×] Gross pathology (0)
• [×] Growth disorders (0)

G cont.

• [+] Gynecology (9)

H

• [+] Hair-related diseases (1)
• [+] Histopathology (1)

I

• [+] Immune system disorders (3)
• [×] Infectious Disease (0)
• [+] Infectious disease (23)
• [+] Infectious diseases (1)

L

• [+] Lists of diseases (2)

M

• [×] Malnutrition (0)
• [+] Medical emergencies (1)
• [×] Musculoskeletal Disease (0)
• [+] Musculoskeletal disorders (2)

N

• [×] Nail diseases (0)
• [+] Nephrology (7)
• [+] Neurological disorders (11)
• [+] Neurology (17)
• [×] Nutritional and Metabolic Disease (0)

O

• [+] Occupational diseases (2)
• [×] Oncologic Disease (0)
• [+] Oncology (16)

O cont.

• [×] Organ disorders (0)
• [×] Organ failure (0)
• [+] Otolaryngology (9)
• [×] Overdose (0)

P

• [+] Pathology (8)
• [+] Plant pathogens and diseases (2)
• [×] Pneumonia (0)
• [×] Porphyrias (0)
• [+] Psychiatry (44)
• [+] Psychological conditions (2)
• [+] Pulmonology (9)

R

• [+] Rare diseases (1)
• [×] Rat carried diseases (0)
• [+] Rheumatology (2)

S

• [×] Skin diseases (0)
• [+] Sleep disorders (1)

T

• [×] Terminal illness (0)

V

• [+] Vascular disorders (1)

Τ

• [+] Disease and disorder templates (1)

• Disease

1

• 17-beta-hydroxysteroid dehydrogenase deficiency (patient information)
• 17-beta-hydroxysteroid dehydrogenase deficiency case study one
• 17-beta-hydroxysteroid dehydrogenase deficiency causes
• 17-beta-hydroxysteroid dehydrogenase deficiency classification
• 17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy
• 17-beta-hydroxysteroid dehydrogenase deficiency CT
• 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis
• 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
• 17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies
• 17-beta-hydroxysteroid dehydrogenase deficiency genotyping
• 17-beta-hydroxysteroid dehydrogenase deficiency historical perspective
• 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms
• 17-beta-hydroxysteroid dehydrogenase deficiency laboratory findings
• 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy
• 17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies
• 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis
• 17-beta-hydroxysteroid dehydrogenase deficiency other diagnostic studies
• 17-beta-hydroxysteroid dehydrogenase deficiency other imaging findings
• 17-beta-hydroxysteroid dehydrogenase deficiency overview
• 17-beta-hydroxysteroid dehydrogenase deficiency pathophysiology
• 17-beta-hydroxysteroid dehydrogenase deficiency pelvic x ray
• 17-beta-hydroxysteroid dehydrogenase deficiency physical examination
• 17-beta-hydroxysteroid dehydrogenase deficiency primary prevention
• 17-beta-hydroxysteroid dehydrogenase deficiency risk factors
• 17-beta-hydroxysteroid dehydrogenase deficiency screening
• 17-beta-hydroxysteroid dehydrogenase deficiency secondary prevention
• 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound

2

• 21-Hydroxylase Deficiency (patient information)
• 21-Hydroxylase Deficiency case study one
• 21-Hydroxylase Deficiency causes
• 21-Hydroxylase Deficiency classification
• 21-Hydroxylase Deficiency cost-effectiveness of therapy
• 21-Hydroxylase Deficiency CT
• 21-Hydroxylase Deficiency differential diagnosis
• 21-Hydroxylase Deficiency epidemiology and demographics
• 21-Hydroxylase Deficiency future or investigational therapies
• 21-Hydroxylase Deficiency genotyping
• 21-Hydroxylase Deficiency historical perspective
• 21-Hydroxylase Deficiency history and symptoms
• 21-Hydroxylase Deficiency laboratory findings
• 21-Hydroxylase Deficiency medical therapy
• 21-Hydroxylase Deficiency molecular genetic studies
• 21-Hydroxylase Deficiency natural history, complications and prognosis
• 21-Hydroxylase Deficiency other diagnostic studies
• 21-Hydroxylase Deficiency other imaging findings
• 21-Hydroxylase Deficiency overview
• 21-Hydroxylase Deficiency pathophysiology
• 21-Hydroxylase Deficiency pelvic x ray
• 21-Hydroxylase Deficiency physical examination
• 21-Hydroxylase Deficiency primary prevention
• 21-Hydroxylase Deficiency risk factors
• 21-Hydroxylase Deficiency screening
• 21-Hydroxylase Deficiency secondary prevention
• 21-Hydroxylase Deficiency social issues
• 21-Hydroxylase Deficiency surgery
• 21-Hydroxylase Deficiency ultrasound

4

• 48, XXXX
• 48, XXYY
• 49 XXXXY syndrome
• 49, XXXXX

5

• 5-alpha-reductase deficiency
• 5-alpha-reductase deficiency (patient information)
• 5-alpha-reductase deficiency case study one
• 5-alpha-reductase deficiency causes
• 5-alpha-reductase deficiency classification
• 5-alpha-reductase deficiency cost-effectiveness of therapy

5 cont.

• 5-alpha-reductase deficiency CT
• 5-alpha-reductase deficiency differential diagnosis
• 5-alpha-reductase deficiency electrocardiogram
• 5-alpha-reductase deficiency epidemiology and demographics
• 5-alpha-reductase deficiency future or investigational therapies
• 5-alpha-reductase deficiency genotyping
• 5-alpha-reductase deficiency historical perspective
• 5-alpha-reductase deficiency history and symptoms
• 5-alpha-reductase deficiency laboratory findings
• 5-alpha-reductase deficiency medical therapy
• 5-alpha-reductase deficiency molecular genetic studies
• 5-alpha-reductase deficiency natural history, complications and prognosis
• 5-alpha-reductase deficiency other diagnostic studies
• 5-alpha-reductase deficiency other imaging findings
• 5-alpha-reductase deficiency overview
• 5-alpha-reductase deficiency pathophysiology
• 5-alpha-reductase deficiency pelvic x ray
• 5-alpha-reductase deficiency physical examination
• 5-alpha-reductase deficiency primary prevention
• 5-alpha-reductase deficiency risk factors
• 5-alpha-reductase deficiency screening
• 5-alpha-reductase deficiency secondary prevention
• 5-alpha-reductase deficiency surgery
• 5-alpha-reductase deficiency ultrasound

A

• Aagenaes syndrome
• Abdallat Davis Farrage syndrome
• Abdominal aortic aneurysm
• Abdominal aortic aneurysm (patient information)
• Abdominal aortic aneurysm abdominal ultrasound
• Abdominal aortic aneurysm abdominal x ray
• Abdominal aortic aneurysm case study one
• Abdominal aortic aneurysm causes
• Abdominal aortic aneurysm classification
• Abdominal aortic aneurysm CT
• Abdominal aortic aneurysm differential diagnosis
• Abdominal aortic aneurysm epidemiology and demographics
• Abdominal aortic aneurysm historical perspective
• Abdominal aortic aneurysm history and symptoms
• Abdominal aortic aneurysm medical therapy
• Abdominal aortic aneurysm MRI
• Abdominal aortic aneurysm natural history
• Abdominal aortic aneurysm other imaging findings
• Abdominal aortic aneurysm overview
• Abdominal aortic aneurysm pathophysiology
• Abdominal aortic aneurysm physical examination
• Abdominal aortic aneurysm prevention
• Abdominal aortic aneurysm risk factors
• Abdominal aortic aneurysm screening
• Abdominal aortic aneurysm surgery
• Abdominal aortic aneurysm ultrasound
• Abdominal wall defect
• Abnormal basal metabolic rate
• ABO incompatibility (patient information)
• Abscess (patient information)
• Absence of gluteal muscle
• Acalvaria
• Acanthocheilonemiasis
• Acanthocytosis
• Acanthocytosis (patient information)
• Acanthocytosis case study one
• Acanthocytosis causes
• Acanthocytosis chorea
• Acanthocytosis cost-effectiveness of therapy
• Acanthocytosis CT
• Acanthocytosis differential diagnosis
• Acanthocytosis epidemiology and demographics
• Acanthocytosis future or investigational therapies

A cont.

• Acanthocytosis history and symptoms
• Acanthocytosis laboratory findings
• Acanthocytosis medical therapy
• Acanthocytosis MRI
• Acanthocytosis natural history, complications and prognosis
• Acanthocytosis other diagnostic studies
• Acanthocytosis other imaging findings
• Acanthocytosis overview
• Acanthocytosis pathophysiology
• Acanthocytosis physical examination
• Acanthocytosis prevention
• Acanthocytosis risk factors
• Acanthocytosis surgery
• ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
• ACC AHA recommendations for evaluation of the unoperated patient in atrial septal defect
• ACC/AHA recommendations for closure of patent ductus arteriosus
• ACC/AHA recommendations for evaluation of patients with unoperated patent ductus arteriosus
• ACC/AHA recommendations for reproduction in levo-transposition of the great arteries
• ACC/AHA recommendations for surgical intervention in L-transposition of the great arteries
• Accessory pancreas
• Achalasia
• Achalasia (patient information)
• Achalasia-addisonian syndrome
• Achard syndrome
• Achard-Thiers Syndrome
• Achlorhydria
• Achlorhydria (patient information)
• Achondroplasia
• Acid - Peptic disease
• Acinic cell carcinoma
• Acinic cell carcinoma (patient information)
• Ackerman syndrome
• Acoustic neuroma (patient information)
• Acquired C1-esterase inhibitor deficiency
• Acquired disorder
• Acquired pure red cell aplasia
• Acral dysostosis - dyserythropoiesis
• Acral necrosis
• Acrodermatitis chronica atrophicans
• Acrodermatitis chronica atrophicans (patient information)
• Acrodermatitis chronica atrophicans case study one
• Acrodermatitis chronica atrophicans causes
• Acrodermatitis chronica atrophicans classification
• Acrodermatitis chronica atrophicans cost-effectiveness of therapy
• Acrodermatitis chronica atrophicans CT
• Acrodermatitis chronica atrophicans differential diagnosis
• Acrodermatitis chronica atrophicans epidemiology and demographics
• Acrodermatitis chronica atrophicans future or investigational therapies
• Acrodermatitis chronica atrophicans historical perspective
• Acrodermatitis chronica atrophicans history and symptoms
• Acrodermatitis chronica atrophicans laboratory findings
• Acrodermatitis chronica atrophicans medical therapy
• Acrodermatitis chronica atrophicans MRI
• Acrodermatitis chronica atrophicans natural history, complications and prognosis
• Acrodermatitis chronica atrophicans other diagnostic studies
• Acrodermatitis chronica atrophicans other imaging findings
• Acrodermatitis chronica atrophicans overview
• Acrodermatitis chronica atrophicans pathophysiology
• Acrodermatitis chronica atrophicans physical examination
• Acrodermatitis chronica atrophicans primary prevention
• Acrodermatitis chronica atrophicans risk factors
• Acrodermatitis chronica atrophicans screening
• Acrodermatitis chronica atrophicans secondary prevention
• Acrodermatitis chronica atrophicans surgery
• Acrodermatitis chronica atrophicans ultrasound
• Acrodermatitis chronica atrophicans x ray